Copyright
©The Author(s) 2020.
World J Hepatol. Oct 27, 2020; 12(10): 792-806
Published online Oct 27, 2020. doi: 10.4254/wjh.v12.i10.792
Published online Oct 27, 2020. doi: 10.4254/wjh.v12.i10.792
Genotypes | OR | 95%CI | P value |
Activity of NASH (A > 2 vs A < 2) | |||
CC vs CG/GG | 0.65 | 0.22-1.88 | 0.433 |
CC vs GG | 17.11 | 1.87 - 156.25 | 0.012 |
Fibrosis (presence vs absence) | |||
CC vs CG/GG | 3.05 | 1.01-9.17 | 0.046 |
CC vs GG | 7.42 | 1.55-35.47 | 0.012 |
- Citation: Lisboa QC, Nardelli MJ, Pereira PA, Miranda DM, Ribeiro SN, Costa RSN, Versiani CA, Vidigal PVT, Ferrari TCA, Couto CA. PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease. World J Hepatol 2020; 12(10): 792-806
- URL: https://www.wjgnet.com/1948-5182/full/v12/i10/792.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i10.792